GNOM logo

GNOM ETF

Profile

Name

Global X Genomics & Biotechnology ETF

Assets under management

$43 million

Expense ratio

0.50%

Asset class

Equity

Domicile

US

Inception date

April 4, 2019

Net asset value

8120 USD

Last ex-dividend date

June 27, 2025

Next ex-dividend date

N/A

Top holdings

Name
Weight
NTRA logo
Natera(NTRA)
4.54 %
ILMN logo
Illumina(ILMN)
4.40 %
QGEN logo
Qiagen NV(QGEN)
4.39 %
4.32 %
MRNA logo
Moderna(MRNA)
4.01 %
3.93 %
3.91 %
3.74 %
VCYT logo
Veracyte(VCYT)
2.77 %
GENSCRIPT BIOTECH CORP(1548.HK)
2.54 %
2.29 %
2.28 %
ASTRAZENECA PLC(AZN.L)
2.15 %
2.11 %
1.95 %
CDNA logo
CareDx(CDNA)
1.29 %
1.24 %
1.09 %

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend per share

Dividend yield

Top holdings

Name
Weight
NTRA logo
Natera(NTRA)
4.54 %
ILMN logo
Illumina(ILMN)
4.40 %
QGEN logo
Qiagen NV(QGEN)
4.39 %
4.32 %
MRNA logo
Moderna(MRNA)
4.01 %
3.93 %
3.91 %
3.74 %
VCYT logo
Veracyte(VCYT)
2.77 %
GENSCRIPT BIOTECH CORP(1548.HK)
2.54 %
2.29 %
2.28 %
ASTRAZENECA PLC(AZN.L)
2.15 %
2.11 %
1.95 %
CDNA logo
CareDx(CDNA)
1.29 %
1.24 %
1.09 %

Analyst ratings

FAQ

  • Does GNOM pay dividends?
  • What stocks are in GNOM?
  • What is the current assets under management for GNOM?
  • What is GNOM average volume?
  • What is GNOM expense ratio?
  • What is GNOM inception date?

Does GNOM pay dividends?

Yes, the Global X Genomics & Biotechnology ETF does pays dividends, with the most recent payment being $0.01 per share. The last ex-dividend date was on June 27, 2025, and the next ex-dividend date has not been announced yet

What stocks are in GNOM?

As of today, Global X Genomics & Biotechnology ETF inlcudes 51 holdings, with 47 of them being companies from 5 different countries and 1 sectors. The most weighted holdings are Alnylam Pharmaceuticals (5.19%), Avidity Biosciences (4.73%) and Natera (4.54%)

What is the current assets under management for GNOM?

Assets under management of Global X Genomics & Biotechnology ETF is $43M

What is GNOM average volume?

Average volume of Global X Genomics & Biotechnology ETF is $79K

What is GNOM expense ratio?

Expense ratio of Global X Genomics & Biotechnology ETF is 0.50%

What is GNOM inception date?

Inception date of Global X Genomics & Biotechnology ETF is April 4, 2019
On this page